- ISIN
- US92337C1045
- CUSIP
- 92337C104
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jan 27, 2012
Highlights
- Market Cap
- $509.67M
- Enterprise Value
- $420.54M
- EPS (TTM)
- -$2.28
- Total Revenue (TTM)
- $49.59M
- Gross Profit (TTM)
- $25.91M
- EBITDA (TTM)
- -$209.89M
- Year Range
- $3.43 - $11.25
- Target Price
- $18.50
- ROA (TTM)
- -85.14%
- ROE (TTM)
- -237.18%
- Avg. Volume (1M)
- 3M
- Avg. Volume Value (1M)
- $14.17M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
VSTM Performance Chart
Verastem, Inc. (VSTM) is down 24.9% since the beginning of the year. At $6 per share, VSTM is trading 48.4% below its 52-week high of $11. Investors who bought $1,000 worth of VSTM shares 5 years ago would now be looking at an investment worth $150.
Loading charts...
Compare this symbol against anything
Returns By Period
Verastem, Inc. (VSTM) has returned -24.87% so far this year and -4.61% over the past 12 months. Over the last ten years, VSTM has returned -9.76% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Verastem, Inc.
- 1D
- -4.92%
- 1M
- 28.89%
- 6M
- -4.92%
- YTD
- -24.87%
- 1Y
- -4.61%
- 3Y*
- -19.16%
- 5Y*
- -31.61%
- 10Y*
- -9.76%
- ALL TIME*
- -19.38%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
VSTM Monthly Returns History
Based on dividend-adjusted daily data since Jan 27, 2012, VSTM's average daily return is +0.08%, while the average monthly return is +1.33%. At this rate, an investment would double in approximately 4.4 years.
Historically, 43% of months were positive and 57% were negative. The best month was May 2023 with a return of +161.1%, while the worst month was Sep 2015 at -70.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.
On a daily basis, VSTM closed higher 46% of trading days. The best single day was May 26, 2023 with a return of +125.6%, while the worst single day was Sep 28, 2015 at -67.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -20.98% | -6.23% | -7.34% | 3.02% | -20.70% | -11.78% | 51.83% | -24.87% | |||||
| 2025 | 17.60% | -7.98% | 7.77% | 24.21% | 0.40% | -44.81% | 48.67% | 49.92% | -4.54% | 7.02% | 12.59% | -27.44% | 49.32% |
| 2024 | 44.35% | 6.04% | -5.30% | -15.42% | -60.32% | -24.75% | -12.75% | -3.85% | 19.60% | 25.75% | 42.02% | -3.18% | -36.49% |
| 2023 | 60.72% | -19.66% | -20.11% | -5.92% | 161.14% | -39.22% | 48.66% | -11.75% | -16.70% | -22.76% | 9.71% | 18.14% | 68.53% |
| 2022 | -25.37% | -21.57% | 17.50% | 0.71% | -9.86% | -9.37% | -7.76% | 8.41% | -26.72% | -50.59% | 9.52% | -12.50% | -80.37% |
| 2021 | -8.45% | 20.51% | 5.11% | 24.29% | 26.06% | 5.17% | -20.64% | -17.96% | 16.23% | -15.58% | 2.69% | -23.22% | -3.76% |
Benchmark Metrics
Verastem, Inc. has an annualized alpha of -0.47%, beta of 1.46, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since January 27, 2012.
- This stock participated in 178.45% of S&P 500 Index downside but only 30.18% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -0.47%
- Beta
- 1.46
- R²
- 0.07
- Upside Capture
- 30.18%
- Downside Capture
- 178.45%
Return for Risk
Risk / Return Rank
VSTM ranks 42 for risk / return — above 42% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Verastem, Inc. (VSTM) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VSTM | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.49 | ||
| Sortino ratioReturn per unit of downside risk | -1.53 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.25 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.09 | 2.00 | -2.09 |
| Martin ratioReturn relative to average drawdown | -0.15 | 8.49 | -8.65 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Verastem, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Verastem, Inc. was 98.96%, occurring on Aug 5, 2024. The portfolio has not yet recovered.
The current Verastem, Inc. drawdown is 97.25%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-98.96%Aug 2024 | 11y 28d | — | 13y 26dJul 2013 - now | — |
-46.13%Nov 2012 | 8mo 15d | 6mo 25d | 1y 3moMar 2012 - Jun 2013 | — |
-7.52%Mar 2012 | 3d | 7d | 10dMar 2012 - Mar 2012 | — |
-6.22%Feb 2012 | 7d | 4d | 11dFeb 2012 - Feb 2012 | — |
-4.56%Feb 2012 | 9d | 7d | 16dJan 2012 - Feb 2012 | — |
Drawdown Indicators
| VSTM | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.96% | -56.78% | -42.18% |
Max Drawdown (1Y)Largest decline over 1 year | -67.97% | -9.10% | -58.87% |
Max Drawdown (3Y)Largest decline over 3 years | -84.36% | -18.90% | -65.46% |
Max Drawdown (5Y)Largest decline over 5 years | -94.29% | -25.43% | -68.86% |
Max Drawdown (10Y)Largest decline over 10 years | -98.16% | -33.92% | -64.24% |
Current DrawdownCurrent decline from peak | -97.25% | -1.58% | -95.67% |
Average DrawdownAverage peak-to-trough decline | -75.49% | -10.70% | -64.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.11% | 2.14% | +36.97% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Verastem, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Verastem, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for VSTM relative to other companies in the Biotechnology industry. Currently, VSTM has a P/S ratio of 10.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with VSTM
Add Verastem, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with VSTM